308 related articles for article (PubMed ID: 9409320)
1. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro.
Muna ZA; Doudin K; Songstad J; Ulvik RJ; Berge RK
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3255-62. PubMed ID: 9409320
[TBL] [Abstract][Full Text] [Related]
2. Tetradecylthioacetic acid and tetradecylselenoacetic acid inhibit lipid peroxidation and interact with superoxide radical.
Muna ZA; Bolann BJ; Chen X; Songstad J; Berge RK
Free Radic Biol Med; 2000 Apr; 28(7):1068-78. PubMed ID: 10832068
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design.
Noguchi N; Okimoto Y; Tsuchiya J; Cynshi O; Kodama T; Niki E
Arch Biochem Biophys; 1997 Nov; 347(1):141-7. PubMed ID: 9344475
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms.
Faure P; Oziol L; Artur Y; Chomard P
Biochimie; 2004 Jun; 86(6):411-8. PubMed ID: 15283976
[TBL] [Abstract][Full Text] [Related]
5. Paracetamol inhibits copper ion-induced, azo compound-initiated, and mononuclear cell-mediated oxidative modification of LDL.
Nenseter MS; Halvorsen B; Rosvold O; Rustan AC; Drevon CA
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1338-44. PubMed ID: 7670947
[TBL] [Abstract][Full Text] [Related]
6. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation.
Belinky PA; Aviram M; Fuhrman B; Rosenblat M; Vaya J
Atherosclerosis; 1998 Mar; 137(1):49-61. PubMed ID: 9568736
[TBL] [Abstract][Full Text] [Related]
7. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions.
Retsky KL; Freeman MW; Frei B
J Biol Chem; 1993 Jan; 268(2):1304-9. PubMed ID: 8419332
[TBL] [Abstract][Full Text] [Related]
8. Effects of antioxidants on the oxidative susceptibility of low-density lipoprotein.
Hirano R; Kondo K; Iwamoto T; Igarashi O; Itakura H
J Nutr Sci Vitaminol (Tokyo); 1997 Aug; 43(4):435-44. PubMed ID: 9328862
[TBL] [Abstract][Full Text] [Related]
9. Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein.
Halvorsen B; Brude I; Drevon CA; Nysom J; Ose L; Christiansen EN; Nenseter MS
J Lipid Res; 1996 Jul; 37(7):1591-600. PubMed ID: 8827529
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the oxidative modification of LDL by nitecapone.
Pentikäinen MO; Lindstedt KA; Kovanen PT
Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):740-7. PubMed ID: 7773727
[TBL] [Abstract][Full Text] [Related]
11. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL.
Hussein O; Schlezinger S; Rosenblat M; Keidar S; Aviram M
Atherosclerosis; 1997 Jan; 128(1):11-8. PubMed ID: 9051193
[TBL] [Abstract][Full Text] [Related]
12. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants.
Brude IR; Drevon CA; Hjermann I; Seljeflot I; Lund-Katz S; Saarem K; Sandstad B; Solvoll K; Halvorsen B; Arnesen H; Nenseter MS
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2576-88. PubMed ID: 9409230
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein.
Yamamoto N; Moon JH; Tsushida T; Nagao A; Terao J
Arch Biochem Biophys; 1999 Dec; 372(2):347-54. PubMed ID: 10600174
[TBL] [Abstract][Full Text] [Related]
14. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation.
Neuzil J; Stocker R
J Biol Chem; 1994 Jun; 269(24):16712-9. PubMed ID: 8206992
[TBL] [Abstract][Full Text] [Related]
15. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
Sakata N; Moh A; Takebayashi S
Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
[TBL] [Abstract][Full Text] [Related]
16. Copper ions promote peroxidation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B100, but they are reduced at other sites on LDL.
Wagner P; Heinecke JW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3338-46. PubMed ID: 9409331
[TBL] [Abstract][Full Text] [Related]
17. Doxazosin treatment and peroxidation of low-density lipoprotein among male hypertensive subjects: in vitro and ex vivo studies.
Brude IR; Drevon CA; Viken K; Arnstad JE; Valnes KN; Nenseter MS
Biochem Pharmacol; 1999 Jul; 58(1):183-91. PubMed ID: 10403533
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant properties of ticlopidine on human low density lipoprotein oxidation.
Lapenna D; de Gioia S; Ciofani G; Bruno C; Porreca E; Pierdomenico SD; Cuccurullo F
FEBS Lett; 1998 Oct; 436(3):357-60. PubMed ID: 9801148
[TBL] [Abstract][Full Text] [Related]
19. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of oxidation of low density lipoprotein by vitamin E and related compounds.
Gotoh N; Noguchi N; Tsuchiya J; Morita K; Sakai H; Shimasaki H; Niki E
Free Radic Res; 1996 Feb; 24(2):123-34. PubMed ID: 8845913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
